Navigation Links
Global Psychiatrists Unite to Improve Services in Mental Health
Date:9/19/2008

, the Department for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Dr John Newcomber, the Department of Psychiatry, Psychology, and Medicine and the Center for Clinical Studies, Washinton University School of Medicine, St.Louis, MO

Dr Mark Olfson, the Department of Psychiatry Columbia University, New York (USA)

Dr Urban Osby, Department of Clinical Neuroscience, Karolinska Institutet, Sweden

Dr Norman Sartorius, Association for Improvement of Mental Health Programmes, Geneva, Switzerland

Dr Jeffrey Lieberman, the Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York

About EUFAMI

EUFAMI, the European Federation of Associations of Families of People with mental illness, is the representative body for family and carer associations throughout Europe, promoting the interests and wellbeing of people with mental illness and their families and carers. It was founded in 1992 under Belgian law and is a member led federation. EUFAMI has 48 national and regional associations as members from 28 countries. EUFAMI is working with major European organizations, such as the EU and the World Health Organization (WHO) to help improve the quality of life of persons affected by mental illness.

---------------------------------

(i) Fleischhacker WW et al. Comorbid Somatic Illness in Patients with Severe Mental Disorders: Clinical, Policy and Research Challenges. J Clin Psychiatry. 2008;69 (4):514-519.


'/>"/>
SOURCE Medizinische Universität Innsbruck Dept. Psychiatry and
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. eResearchTechnology, Inc. to Present at the UBS Global Life Sciences Conference on September 23rd, 2008
2. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
3. BioVex to Present at the UBS Global Life Sciences Conference
4. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
5. CryoLife to Present at UBS Global Life Sciences Conference
6. Medarex to Present at the UBS Global Life Sciences Conference
7. Sigma-Aldrich to Present at the UBS 2008 Global Life Sciences Conference on September 24, 2008
8. Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
9. Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
10. Sinovac to Present at the 2008 UBS Global Life Sciences Conference
11. Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Tampa, Florida (PRWEB) , ... June 30, 2015 ... ... medical cannabis digital media company, launched “Cannavoices,” an unprecedented digital video and ... the largest but also the most dynamic collection of legal medical cannabis stories ...
(Date:6/29/2015)...   Pharnext SAS today announced that data related ... of Charcot-Marie-Tooth Type 1A (CMT1A), is being presented in four ... Society (PNS) Biennial Meeting at the Quebec Congress Center in ... July 2, 2015. At Poster Viewing Session 4, ... to 7p.m. EDT: Poster 23: "A Meta-Analysis ...
(Date:6/29/2015)... ... June 29, 2015 , ... The global microfluidics ... the forecast period (2015 to 2020). The market is mainly driven by the ... funding for R&D. However, lack of adequate healthcare and research infrastructure in emerging ...
(Date:6/29/2015)... June 29, 2015  AACC, a global scientific ... through laboratory medicine, is pleased to announce that ... Chemistry , has increased to 7.9 in the ... places Clinical Chemistry in the top ... significant influence of the research it publishes on ...
Breaking Biology Technology:Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3Pharnext's PXT-3003 Featured in Multiple Presentations at 2015 Peripheral Nerve Society Biennial Meeting 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 2AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 3
... took his computer to boot up, Klui began to think ... enormous quantities of data, but they are slow; every time ... is transferred from the hard disk into RAM (random access ... energy consumption runs into the hundreds of millions of dollars ...
... Nov. 15, 2010, PRNewswire-Asia/ -- Tiens Biotech Group (USA), Inc. (the ... www.tiens-bio.com , today announced financial results ... Revenue for the third quarter of 2010 was $10.4 ... Revenue for the nine months ended September 30, 2010 was $30.0 ...
... Celladon Corp., a biopharmaceutical company focused on ... cardiovascular diseases, today announced that 12-month data from ... demonstrated significant improvements in clinical outcomes and key ... with the genetically-targeted enzyme replacement therapy. ...
Cached Biology Technology:Racetrack memory 2Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 2Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 3Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 4Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 5Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 6Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 7Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 8Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results 9Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Clinical Improvements in Patients for 12 Months Compared with Placebo 2Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Clinical Improvements in Patients for 12 Months Compared with Placebo 3Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Clinical Improvements in Patients for 12 Months Compared with Placebo 4
(Date:6/26/2015)... 26, 2015 ATL Technology, LLC, a top provider ... in single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Jose, Costa Rica ). This acquisition will ... with ATL Technology,s existing facility in Costa ...
(Date:6/24/2015)... 24, 2015 This report provides market analysis ... six years. It contains an analysis of the drivers, ... their impact from the short, medium, and long term ... industry, market, and technology trends that currently, prevail in ... concerned authorities to efficiently manage the increasing marine traffic ...
(Date:6/23/2015)... 22, 2015 Research ... of the "Body-Worn Temperature Sensors Market - ... Forecast 2014 - 2020" report to their ... of the global body-worn temperature sensors market. The ... on the basis of types, care setting, patient ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... oysters on a hot sunny afternoon? Make the most ... shown that global warming increases the sensitivity of oysters ... in polluted areas. Dr. Gisela Lannig from the University ... cadmium poisoning in eastern oysters (Crassostrea virginica) on Monday ...
... a highly effective analgesic, its clinical utility is severely ... for increasing doses to maintain analgesic effect, and the ... of Current Biology, researchers report a new study showing ... along with small doses of two versions of methadone, ...
... for viral-based therapies for cancer , Researchers at Columbia ... work to develop the next generation of effective viral-based ... with genetically engineered viruses studied in mice, published today ... the National Academy of Sciences (PNAS), bring us significantly ...
Cached Biology News:Opiate cocktail may spare cells from morphine's dark side 2Columbia scientists develop cancer terminator viruses 2Columbia scientists develop cancer terminator viruses 3